Navigation Links
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018
Date:8/1/2014

DUBLIN, Aug. 1, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study.

It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.

The analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

18. Key Vendor Analysis

19. Other Reports in this Series

Companies Mentioned:

  • Affymetrix Inc.
  • Illumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Douglas Scientific Llc.
  • Fluidigm Corp.
  • Luminex Corp.
  • PREMIER Biosoft Intl.
  • Promega Corp
  • Qiagen N. V.
  • Sequenom Inc.
  • WaferGen Biosystems Inc.

For more information visit http://www.researchandmarkets.com/research/wn2znf/global_single

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR
2. Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com
3. Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research
4. Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research
5. Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina
6. Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020
7. ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment
8. Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth
9. Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research
10. Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
11. Global Synthetic Biology Market 2014-2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):